111.51
-3.95%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Valiant Laboratories
Its shares trade on NSE under the ticker VALIANTLAB.NS. It has been listed since 6 October 2023. In the fiscal year to 31 March 2026, it reported revenue of ₹2.37bn and a net loss of ₹32.7m. At that date it held total assets of ₹4.64bn and shareholders' equity of ₹3.11bn.
Valiant Laboratories Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2023-10-06. Valiant Laboratories Limited is an India-based active pharmaceutical ingredient (API)manufacturing company. The firm is engaged in manufacturing and dealing in specialty chemicals and pharma intermediates in India and abroad. The firm is focused on manufacturing paracetamol API/bulk drug, which has various applications like uses in treatment of conditions, such as headache, muscle ache, arthritis, back ache, toothache, cold and fever. The company operates in a single location manufacturing facility at Tarapur industrial estate. Its manufacturing facility is located at a distance of approximately 150 kilometers (km) from Nhava Sheva Port (JNPT). The Company’s subsidiary is VALIANT ADVANCED SCIENCES PRIVATE LIMITED.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 6 Oct 2023
- Website
- valiantlabs.in ↗
Leadership
Pay as last reported
- Mr. Paresh ShahChief Financial Officer, Executive Director, since 2021
- Ms. Prajakta PatilCompliance Officer, Company Secretary
- Shri. Santosh VoraManaging Director, Executive Director, since 2021
- Ms. Archana KoliPurchase Manager
- Mr. Chandrakant MandhareHead - Accounts and Finance
- Ms. Kiran MudaliarAssistant Manager - Accounts
- Mr. Bhanudas PatilQuality Control Manager
- Mr. Nilesh PatilHead - Research and Development
- Mr. Bhupendra RaulQuality Assurance Manager
- Mr. Jyotibhushan SinghHead - Unit
- Mr. Sandeep GuptaNon-Executive Director
- Mr. Shantilal VoraNon-Executive Director, since 2021₹1.5m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Valiant Laboratories Ltd manufactures paracetamol API for treating headache and fever conditions.
- The firm deals in specialty chemicals and pharma intermediates in India and abroad.
- The company operates a single manufacturing facility at Tarapur industrial estate in India.
Weaknesses
- The company relies on a single location manufacturing facility at Tarapur industrial estate.
- Valiant Laboratories Ltd has only one subsidiary named VALIANT ADVANCED SCIENCES PRIVATE LIMITED.
- The firm focuses primarily on manufacturing paracetamol API with limited product diversity.
Opportunities
- The firm can expand its specialty chemicals and pharma intermediates business in India.
- Valiant Laboratories Ltd can leverage its proximity to Nhava Sheva Port for exports.
- The company can grow its API manufacturing capacity to meet global demand.
Threats
- Valiant Laboratories Ltd faces risks from its single location manufacturing facility at Tarapur.
- The company depends heavily on the paracetamol API market for its revenue.
- Operational disruptions at the Tarapur industrial estate could impact production significantly.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.